Phase 2 Study of Bexxar in Relapsed/Refractory Diffuse Large Cell Lymphoma (DLCL)
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Iodine-131 tositumomab (Primary) ; Diphenhydramine; Paracetamol; Potassium iodide
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 14 Feb 2011 Planned end date changed from Aug 2007 to Aug 2011 as reported by ClinicalTrials.gov.
- 18 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 13 Jul 2008 Corixa Corp reported as as trial sponsor by ClinicalTrials.gov.